Prelude Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$16.8M |
| 2 |
Unity
U
|
+$14M |
| 3 |
AIFC
AI Financial Corp
AIFC
|
+$13.8M |
| 4 |
CYBR
CyberArk
CYBR
|
+$12.6M |
| 5 |
Norfolk Southern
NSC
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$13.2M |
| 2 |
Tesla
TSLA
|
+$12.9M |
| 3 |
Baidu
BIDU
|
+$11.9M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10M |
| 5 |
AMED
Amedisys
AMED
|
+$8.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.32% |
| 2 | Communication Services | 11.38% |
| 3 | Healthcare | 11.08% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Financials | 9.07% |
Similar funds
Prelude Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.
- Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
- Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
- Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
- Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
- Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
- Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
- Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.
Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.